These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28667875)

  • 1. Discovery of potent IDO1 inhibitors derived from tryptophan using scaffold-hopping and structure-based design approaches.
    Zou Y; Wang Y; Wang F; Luo M; Li Y; Liu W; Huang Z; Zhang Y; Guo W; Xu Q; Lai Y
    Eur J Med Chem; 2017 Sep; 138():199-211. PubMed ID: 28667875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel IDO1 inhibitors targeting the protein's apo form through scaffold hopping from holo-IDO1 inhibitor.
    Wu Y; Duan Q; Zou Y; Zhu Q; Xu Y
    Bioorg Med Chem Lett; 2021 Nov; 52():128373. PubMed ID: 34560264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of IDO1 and DNA dual targeting antitumor agents.
    Fang K; Wu S; Dong G; Wu Y; Chen S; Liu J; Wang W; Sheng C
    Org Biomol Chem; 2017 Dec; 15(47):9992-9995. PubMed ID: 29177308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation.
    Xu X; Ren J; Ma Y; Liu H; Rong Q; Feng Y; Wang Y; Cheng Y; Ge R; Li Z; Bian J
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):250-263. PubMed ID: 30734612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays.
    Ge H; Mao L; Zhao J; Wang Y; Shi D; Yang X; Wang X; Liu H; Yao X
    J Comput Aided Mol Des; 2021 May; 35(5):679-694. PubMed ID: 33905074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of imidazoleisoindole derivatives as potent IDO1 inhibitors: Design, synthesis, biological evaluation and computational studies.
    Zou Y; Wang F; Wang Y; Sun Q; Hu Y; Li Y; Liu W; Guo W; Huang Z; Zhang Y; Xu Q; Lai Y
    Eur J Med Chem; 2017 Nov; 140():293-304. PubMed ID: 28963992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and optimization of substituted oxalamides as novel heme-displacing IDO1 inhibitors.
    Steeneck C; Kinzel O; Anderhub S; Hornberger M; Pinto S; Morschhaeuser B; Albers M; Sonnek C; Czekańska M; Hoffmann T
    Bioorg Med Chem Lett; 2021 Feb; 33():127744. PubMed ID: 33333163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Röhrig UF; Majjigapu SR; Vogel P; Zoete V; Michielin O
    J Med Chem; 2015 Dec; 58(24):9421-37. PubMed ID: 25970480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel High Throughput Virtual Screening Protocol to Discover New Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Xu H; Song Y; Yang Q
    Chem Pharm Bull (Tokyo); 2017; 65(8):714-717. PubMed ID: 28768924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
    Fung SP; Wang H; Tomek P; Squire CJ; Flanagan JU; Palmer BD; Bridewell DJ; Tijono SM; Jamie JF; Ching LM
    Bioorg Med Chem; 2013 Dec; 21(24):7595-603. PubMed ID: 24262887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.
    Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH
    Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors.
    Pan L; Zheng Q; Chen Y; Yang R; Yang Y; Li Z; Meng X
    Eur J Med Chem; 2018 Sep; 157():423-436. PubMed ID: 30103191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Zheng Y; Stafford PM; Stover KR; Mohan DC; Gupta M; Keske EC; Schiavini P; Villar L; Wu F; Kreft A; Thomas K; Raaphorst E; Pasangulapati JP; Alla SR; Sharma S; Mittapalli RR; Sagamanova I; Johnson SL; Reed MA; Weaver DF
    ChemMedChem; 2021 Jul; 16(14):2195-2205. PubMed ID: 33759400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
    Weng T; Qiu X; Wang J; Li Z; Bian J
    Eur J Med Chem; 2018 Jan; 143():656-669. PubMed ID: 29220788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies.
    Griglio A; Torre E; Serafini M; Bianchi A; Schmid R; Coda Zabetta G; Massarotti A; Sorba G; Pirali T; Fallarini S
    Bioorg Med Chem Lett; 2018 Feb; 28(4):651-657. PubMed ID: 29398544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.
    Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X
    Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
    Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
    Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
    Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
    Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
    Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 4-Amino-1,2,3-Triazole Inhibitors of Indoleamine 2,3-Dioxygenase Form a Long-Lived Complex with the Enzyme and Display Exquisite Cellular Potency.
    Alexandre JAC; Swan MK; Latchem MJ; Boyall D; Pollard JR; Hughes SW; Westcott J
    Chembiochem; 2018 Mar; 19(6):552-561. PubMed ID: 29240291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.